Clinical Actionability of Genetic Findings in Cerebral Palsy
Sara A. Lewis(Barrow Neurological Institute), Michael C. Kruer(Sanford Research), Maya Chopra(Boston Children's Hospital), Jason B. Carmel(United Cerebral Palsy), Darcy Fehlings(University of Toronto), Jennifer Bain(Rutgers New Jersey Medical School), Halie May(Columbia University), Julie S. Cohen(Kennedy Krieger Institute), Richard F. Wintle(Hospital for Sick Children), Reeval Segel(Shaare Zedek Medical Center), Michael Zech(University of Bayreuth), Siddharth Srivastava(Boston Children's Hospital), Bhooma R. Aravamuthan(Washington University in St. Louis), N Haque(Barrow Neurological Institute), Michael Fahey(Monash University)
Cited by 12
Related Papers
Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies
|The Lancet Neurology|2014|615
Danube loess stratigraphy — Towards a pan-European loess stratigraphic model
|Earth-Science Reviews|2015|313
Acute Infantile Liver Failure Due to Mutations in the TRMU Gene
|The American Journal of Human Genetics|2009|227
A large data resource of genomic copy number variation across neurodevelopmental disorders
|npj Genomic Medicine|2019|199